The SEC's complaint in its case against Allergan included a charge that the company:
A) Used off-balance sheet entities to manipulate earnings
B) Falsified inventory values to inflate earnings
C) Used non-GAAP measures to meet EPS estimates
D) Used EBITDA to obscure reported earnings

Question

Quizplus · Accepted Answer

The SEC's complaint in the case against Allergan specifically stated that the company used non-GAAP measures to meet EPS estimates.

The SEC's Complaint in Its Case Against Allergan Included a Charge